Timothy McCormick

<i>In Vitro</i> and <i>in Vivo</i> Characterization of a Potential Universal Placebo Designed for Use in Vaginal Microbicide Clinical Trials

Deborah Tien, Roger L. Schnaare, Feirong Kang et al. · AIDS Research and Human Retroviruses · 2005 · 177 citations

Public Health, Pharmaceutics, Drug Delivery +14

First Phase 1 Double-Blind, Placebo-Controlled, Randomized Rectal Microbicide Trial Using UC781 Gel with a Novel Index of Ex Vivo Efficacy

Peter A. Anton, Terry Saunders, Julie Elliott et al. · PLoS ONE · 2011 · 83 citations · Full text

Public Health, Immunology, Infectious Diseases +17

Randomized, placebo controlled phase I trial of safety, pharmacokinetics, pharmacodynamics and acceptability of tenofovir and tenofovir plus levonorgestrel vaginal rings in women

Andrea R. Thurman, Jill L. Schwartz, Vivian Brache et al. · PLoS ONE · 2018 · 61 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Expression, purification, and characterization of recombinant cyanovirin-N for vaginal anti-HIV microbicide development

Diana M. Colleluori, Deborah Tien, Feirong Kang et al. · Protein Expression and Purification · 2004 · 53 citations

Life Sciences, Immunology, Microbiology +11

A Randomized Six-Day Safety Study of an Antiretroviral Microbicide Candidate UC781, a Non-Nucleoside Reverse Transcriptase Inhibitor

Jill L. Schwartz, G. Kovalevsky, Jaim-Jou Lai et al. · Sexually Transmitted Diseases · 2008 · 53 citations

Pharmacy, Gynecology, Pharmacotherapy +13